Abstract
AbstractBackground:Drop-out rates from evidence-based interventions for people with a diagnosis of personality disorder (PD) are high. The COVID-19 pandemic has likely exacerbated barriers to engagement with the introduction of virtual working. Virtual therapy has a good evidence-base for Axis I disorders, but limited research for Axis II disorders.Aims:To investigate facilitators and barriers to engagement in a Tier 3 PD service virtual group programme.Method:A virtual group programme was developed in collaboration with service members, and analysed members’ attendance rates over a 5-month period pre- and post-COVID-19. Thematic analysis of semi-structured telephone interviews with 38 members is reported, describing their experience of the virtual group programme.Results:Attendance rates were significantly higher pre-COVID (72%) than post-COVID (50%). Thematic analysis highlighted key barriers to attendance were: practical issues, low motivation, challenges of working in a group online and feeling triggered at home. Main promoters of engagement were: feeling valued, continued sense of connection and maintaining focus on recovery.Discussion:The results suggest that the pandemic has exacerbated relational and practical barriers to engagement in a Tier 3 PD service. Ways of enhancing engagement are discussed, as well as preliminary recommendation for services offering virtual therapy to people with a diagnosis of PD.
Publisher
Cambridge University Press (CUP)
Subject
Clinical Psychology,General Medicine
Reference65 articles.
1. Clinical management of common presentations of patients diagnosed with BPD during the COVID-19 pandemic: the contribution of the MBT framework
2. Community and clinical epidemiology of borderline personality disorder;Ellison;Psychiatric Clinics,2018
3. Royal College of Psychiatrists (2020). Services for People Diagnosable with Personality Disorder.
4. Comorbidity of borderline personality disorder: current status and future directions;Shah;Psychiatric Clinics,2018
5. Patients with mental health disorders in the COVID-19 epidemic